Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New radiation technique aims to spare salivary glands and prevent dry mouth

NCT ID NCT06276946

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study aimed to test whether using MRI scans to guide radiation planning could reduce dry mouth in people with oropharynx cancer. The idea was to protect the parotid ducts, which contain stem cells important for saliva production. However, the study was withdrawn before any patients were enrolled, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology

    Chapel Hill, North Carolina, 27599, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

radiotherapy

What this could lead to

If successful, this approach could reduce severe dry mouth after radiation for head and neck cancer, improving patients' quality of life.

What could go wrong

The study was withdrawn before enrolling any participants, so no data is available. It is unclear if the technique would work or be practical in routine care.

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms oropharynx cancer Xerostomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.